Radiotherapy strategy for advanced esophageal cancer
10.3760/cma.j.cn113030-20220704-00230
- VernacularTitle:晚期食管癌的放射治疗策略
- Author:
Yuanyuan TIAN
1
;
Jun LEI
;
Yongshun CHEN
Author Information
1. 武汉大学人民医院肿瘤中心，武汉 430060
- Keywords:
Esophageal neoplasms, advanced;
Radiotherapy;
Oligometastases;
Multiple metastases;
Eligible population
- From:
Chinese Journal of Radiation Oncology
2023;32(7):644-650
- CountryChina
- Language:Chinese
-
Abstract:
Advanced esophageal cancer accounts for a large proportion of all esophageal cancer cases, and the treatment modality recommended by the current guidelines is systemic treatment. Radiotherapy is an important treatment option for malignant tumors, which is widely applied in clinical practice. Retrospective analysis and small-sample prospective studies have shown that combination of radiotherapy with chemotherapy, targeted therapy, and immunotherapy has the advantages of improving disease control rate, symptom remission rate and prolonging survival of advanced esophageal cancer patients. Therefore, it is an important clinical topic issue to make better use of the advantages of radiotherapy for esophageal cancer, such as rapid relief of symptoms, durable efficacy, and stimulation of immune neoantigens, etc. To optimize the treatment strategy of advanced esophageal cancer, the radiotherapy strategy for esophageal cancer with oligometastases or multiple metastases, and the screening method for the eligible population for radiotherapy were reviewed, aiming to provide reference for improving the status of radiotherapy in comprehensive treatment of advanced esophageal cancer.
